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Marcel Dekker, Inc., 1983, 311 pp. $45.00.
In October 1982, virologists, molecular biologists, epidemiologists, diagnosti-
cians, oncologists, and pathologists from around the world gathered in Munich,
West Germany, for the Second International Max von Pettenkofer Symposium on
Viral Hepatitis. The purpose of this meeting was to focus on the common interests
of clinicians and laboratory investigators in the ever-burgeoning discipline of viral
hepatitis research.
Summaries ofthe 66 papers that were presented at themeeting appear in this small
volume. The papers are very brief and are published under twelve major headings
which include, among others: pathology, characterization and propagation of
hepatitis viruses, molecular biology of hepatitis viruses, epidemiology of non-A,
non-B hepatitis and delta agent, HBV and primary liver cell carcinoma, treatment,
and immune prophylaxis. Most of the summaries are three to five pages in length
and include a few tables, figures, and a handful of relevant references. Viewed in
toto, these precis provide an excellent overview of work being done in this rapidly
progressing field of virology. Each mini-paper provides nuggets of compressed and
highly predigested information. Obviously, the reader would have to do some
research of his own in order to flesh out any particular subject of interest.
Nevertheless, it is staggering to regard the work that has been done in the past
several years. For example, hepatitis A now grows in cell culture and has been
cloned. The hepatitis B virus and its genome are well-characterized, its nucleotides
have been sequenced, its genome has been mapped, and the amino acid sequences of
some ofits gene products have been determined. Noninfectious hepatitis B vaccines
are on the market, and newer vaccines, produced by cloning the genome in pro- or
eukaryotic cells or by constructing synthetic polypeptides, are being developed.
More is being learned about the startling association between hepatitis B and
primary hepatocellular carcinoma and about the delta agent, a defective RNA virus.
Non-A, non-B hepatitis remains a conundrum-many "virus-like" particles and
many serologic tests have been described. We will have to wait to discover which
among this line-up of suspects are the real culprits.
This book would be valuable to virologists and hepatologists who desire an up-to-
date panoramic view of this diverse group of agents and diseases. It should be
regarded as a handy summation of work in progress.
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